Predictions
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€2.81
24.12.22
24.12.22
-
24.12.23
24.12.23
-25.37%
01.11.23
01.11.23
Could be worthwhile Investment >10% per year
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
24.12.22
24.12.22
-
24.12.23
24.12.23
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Hexo Corp.
Start price
Target price
Perf. (%)
€0.91
24.12.22
24.12.22
-
24.12.23
24.12.23
-31.30%
29.07.23
29.07.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Good culture
Future proof or reliable business model
Oncodesign S.A.
Start price
Target price
Perf. (%)
€14.28
23.12.22
23.12.22
-
-
24.12.22
24.12.22
Could be worthwhile Investment >10% per year
Coherus Bioscien.
Start price
Target price
Perf. (%)
€7.52
23.12.22
23.12.22
€9.00
30.09.25
30.09.25
-79.54%
12.11.23
12.11.23
Could be very worthwhile Investment >20% year
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€34.35
22.12.22
22.12.22
-
22.12.23
22.12.23
13.25%
24.08.23
24.08.23
Glycomimetics Inc.
Start price
Target price
Perf. (%)
€2.05
21.12.22
21.12.22
€4.00
31.12.24
31.12.24
-34.96%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.32
21.12.22
21.12.22
€11.00
31.03.24
31.03.24
29.21%
28.12.22
28.12.22
Could be very worthwhile Investment >20% year
Viking Therapeutics Inc
Start price
Target price
Perf. (%)
€6.10
19.12.22
19.12.22
€18.00
31.12.24
31.12.24
226.15%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.76
11.12.22
11.12.22
-
11.12.23
11.12.23
-6.82%
06.03.23
06.03.23
Could be worthwhile Investment >10% per year
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.24
08.12.22
08.12.22
-
08.12.23
08.12.23
-6.85%
24.12.22
24.12.22
Risky Investment
Immunic Inc.
Start price
Target price
Perf. (%)
€1.33
27.11.22
27.11.22
-
27.11.23
27.11.23
-14.77%
11.12.22
11.12.22
Risky Investment
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€0.34
19.11.22
19.11.22
€0.10
19.11.23
19.11.23
-5.60%
27.02.23
27.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.80
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-41.00%
20.11.23
20.11.23
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
MacroGenics Inc.
Start price
Target price
Perf. (%)
€6.85
17.11.22
17.11.22
-
17.11.23
17.11.23
-17.52%
27.11.22
27.11.22
Risky Investment
MacroGenics Inc.
Start price
Target price
Perf. (%)
€7.15
13.11.22
13.11.22
-
13.11.23
13.11.23
-20.98%
26.11.22
26.11.22
Could be worthwhile Investment >10% per year
Mediclin AG
Start price
Target price
Perf. (%)
€3.32
13.11.22
13.11.22
€3.00
13.11.23
13.11.23
-0.60%
26.11.22
26.11.22
EBIT growth >5% per year expected
positive Cash Flow expected
Top 10 in its market
Future proof or reliable business model
Acelrx Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.91
08.11.22
08.11.22
€4.20
08.11.23
08.11.23
23.85%
16.11.22
16.11.22
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€38.20
04.11.22
04.11.22
€32.00
31.12.24
31.12.24
6.81%
21.12.22
21.12.22
Could be very worthwhile Investment >20% year
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.62
03.11.22
03.11.22
-
03.11.23
03.11.23
13.26%
10.11.22
10.11.22
Could be very worthwhile Investment >20% year
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€42.60
01.11.22
01.11.22
€55.00
31.12.24
31.12.24
-10.33%
04.11.22
04.11.22
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.47
31.10.22
31.10.22
€18.00
31.12.24
31.12.24
19.77%
31.10.22
31.10.22
Could be very worthwhile Investment >20% year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€2.68
29.10.22
29.10.22
-
29.10.23
29.10.23
40.63%
30.10.23
30.10.23
Could be worthwhile Investment >10% per year